Difference between revisions of "FEMA5:Volunteer Assignments and Opportunities"

From Compendium of Cancer Genome Aberrations
Jump to navigation Jump to search
VisualWikitext
[checked revision][checked revision]
(Created page with "Welcome! For assignments, please see the "Author" column below (highlighted blue). If empty (no name is present), please volunteer to create content for that disease! To vo...")
 
 
(12 intermediate revisions by the same user not shown)
Line 6: Line 6:
  
 
To volunteer, please '''[[Mailto:CCGA@cancergenomics.org <u>Contact us</u>]]''' with your page of interest.
 
To volunteer, please '''[[Mailto:CCGA@cancergenomics.org <u>Contact us</u>]]''' with your page of interest.
 +
 +
__TOC__
 
{| class="wikitable" style="margin:auto"
 
{| class="wikitable" style="margin:auto"
 
|+<big>WHO Classification of Female Genital Tumours (5th Edition) Content</big>
 
|+<big>WHO Classification of Female Genital Tumours (5th Edition) Content</big>
Line 17: Line 19:
 
!'''Notes'''
 
!'''Notes'''
 
|-
 
|-
 +
|
 +
==== CHAPTER 2 (TUMOURS OF THE OVARY) ====
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 +
|-
 +
|[[FEMA5:Serous_cystadenoma,_adenofibroma,_and_surface_papilloma_of_the_ovary|Serous cystadenoma, adenofibroma, and surface papilloma of the ovary]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[FEMA5:Serous_borderline_tumour_of_the_ovary|Serous borderline tumour of the ovary]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[FEMA5:Low-grade_serous_carcinoma_of_the_ovary|Low-grade serous carcinoma of the ovary]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[FEMA5:High-grade_serous_carcinoma_of_the_ovary|High-grade serous carcinoma of the ovary]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[FEMA5:Mucinous_cystadenoma_and_adenofibroma|Mucinous cystadenoma and adenofibroma]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[FEMA5:Mucinous_borderline_tumour_|Mucinous borderline tumour]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[FEMA5:Mucinous_carcinoma_of_the_ovary|Mucinous carcinoma of the ovary]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[FEMA5:Endometrioid_cystadenoma_and_adenofibroma|Endometrioid cystadenoma and adenofibroma]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[FEMA5:Endometrioid_borderline_tumour|Endometrioid borderline tumour]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[FEMA5:Endometrioid_carcinoma_of_the_ovary|Endometrioid carcinoma of the ovary]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[FEMA5:Clear_cell_cystadenoma_and_adenofibroma|Clear cell cystadenoma and adenofibroma]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[FEMA5:Clear_cell_borderline_tumour|Clear cell borderline tumour]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[FEMA5:Clear_cell_carcinoma_of_the_ovary|Clear cell carcinoma of the ovary]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[FEMA5:Seromucinous_cystadenoma_and_adenofibroma|Seromucinous cystadenoma and adenofibroma]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[FEMA5:Seromucinous_borderline_tumour|Seromucinous borderline tumour]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[FEMA5:Brenner_tumour_|Brenner tumour]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[FEMA5:Borderline_Brenner_tumour|Borderline Brenner tumour]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[FEMA5:Malignant_Brenner_tumour_|Malignant Brenner tumour]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[FEMA5:Mesonephric-like_adenocarcinoma|Mesonephric-like adenocarcinoma]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[FEMA5:Undifferentiated_and_dedifferentiated_carcinomas_of_the_ovary|Undifferentiated and dedifferentiated carcinomas of the ovary]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[FEMA5:Carcinosarcoma_of_the_ovary|Carcinosarcoma of the ovary]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[FEMA5:Mixed_carcinoma_of_the_ovary|Mixed carcinoma of the ovary]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[FEMA5:Endometrioid_stromal_sarcoma_of_the_ovary|Endometrioid stromal sarcoma of the ovary]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[FEMA5:Smooth_muscle_tumours_of_the_ovary|Smooth muscle tumours of the ovary]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[FEMA5:Ovarian_myxoma_|Ovarian myxoma]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[FEMA5:Adenosarcoma_of_the_ovary|Adenosarcoma of the ovary]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[FEMA5:Ovarian_fibroma_|Ovarian fibroma]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[FEMA5:Thecoma_|Thecoma]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[FEMA5:Luteinized_thecoma_associated_with_sclerosing_peritonitis_|Luteinized thecoma associated with sclerosing peritonitis]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[FEMA5:Sclerosing_stromal_tumour_|Sclerosing stromal tumour]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[FEMA5:Microcystic_stromal_tumour_|Microcystic stromal tumour]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[FEMA5:Signet-ring_stromal_tumour_|Signet-ring stromal tumour]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[FEMA5:Leydig_cell_tumour_|Leydig cell tumour]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[FEMA5:Steroid_cell_tumour_|Steroid cell tumour]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[FEMA5:Ovarian_fibrosarcoma_|Ovarian fibrosarcoma]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[FEMA5:Adult_granulosa_cell_tumour_|Adult granulosa cell tumour]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[FEMA5:Juvenile_granulosa_cell_tumour_|Juvenile granulosa cell tumour]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[FEMA5:Sertoli_cell_tumour_|Sertoli cell tumour]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[FEMA5:Sex_cord_tumour_with_annular_tubules_|Sex cord tumour with annular tubules]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[FEMA5:Sertoli-Leydig_cell_tumour|Sertoli-Leydig cell tumour]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[FEMA5:Sex_cord-stromal_tumour_NOS|Sex cord-stromal tumour NOS]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[FEMA5:Gynandroblastoma|Gynandroblastoma]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[FEMA5:Mature_teratoma_of_the_ovary|Mature teratoma of the ovary]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[FEMA5:Immature_teratoma_of_the_ovary|Immature teratoma of the ovary]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[FEMA5:Dysgerminoma_|Dysgerminoma]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[FEMA5:Yolk_sac_tumour_|Yolk sac tumour]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[FEMA5:Embryonal_carcinoma_|Embryonal carcinoma]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[FEMA5:Non-gestational_choriocarcinoma_|Non-gestational choriocarcinoma]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[FEMA5:Mixed_germ_cell_tumour_of_the_ovary|Mixed germ cell tumour of the ovary]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[FEMA5:Struma_ovarii_|Struma ovarii]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[FEMA5:Ovarian_carcinoid|Ovarian carcinoid]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[FEMA5:Neuroectodermal-type_tumours|Neuroectodermal-type tumours]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[FEMA5:Monodermal_cystic_teratoma_|Monodermal cystic teratoma]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[FEMA5:Somatic_neoplasms_arising_from_teratomas|Somatic neoplasms arising from teratomas]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[FEMA5:Gonadoblastoma|Gonadoblastoma]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[FEMA5:Mixed_germ_cell-sex_cord-stromal_tumour,_unclassified|Mixed germ cell-sex cord-stromal tumour, unclassified]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[FEMA5:Rete_cystadenoma,_adenoma,_and_adenocarcinoma|Rete cystadenoma, adenoma, and adenocarcinoma]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[FEMA5:Wolffian_tumour_of_the_ovary|Wolffian tumour of the ovary]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[FEMA5:Solid_pseudopapillary_tumour_|Solid pseudopapillary tumour]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[FEMA5:Small_cell_carcinoma_of_the_ovary,_hypercalcaemic_type|Small cell carcinoma of the ovary, hypercalcaemic type]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[FEMA5:Wilms_tumour_|Wilms tumour]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[FEMA5:Follicle_cyst|Follicle cyst]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[FEMA5:Corpus_luteum_cyst|Corpus luteum cyst]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[FEMA5:Large_solitary_luteinized_follicle_cyst|Large solitary luteinized follicle cyst]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[FEMA5:Hyperreactio_luteinalis|Hyperreactio luteinalis]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[FEMA5:Pregnancy_luteoma|Pregnancy luteoma]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[FEMA5:Stromal_hyperplasia_and_hyperthecosis|Stromal hyperplasia and hyperthecosis]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[FEMA5:Fibromatosis_and_massive_oedema|Fibromatosis and massive oedema]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[FEMA5:Leydig_cell_hyperplasia|Leydig cell hyperplasia]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[FEMA5:Metastases_to_the_ovary|Metastases to the ovary]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|
 +
==== CHAPTER 3 (ENDOMETRIOSIS AND RELATED CONDITIONS) ====
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 +
|-
 +
|[[FEMA5:Endometriosis_and_derived_tumours|Endometriosis and derived tumours]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|
 +
==== CHAPTER 4 (TUMOURS OF THE PERITONEUM) ====
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 +
|-
 +
|[[FEMA5:Adenomatoid_tumour_|Adenomatoid tumour]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[FEMA5:Well-differentiated_papillary_mesothelial_tumour_|Well-differentiated papillary mesothelial tumour]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[FEMA5:_Mesothelioma_| Mesothelioma]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[FEMA5:Serous_borderline_tumour_of_the_peritoneum|Serous borderline tumour of the peritoneum]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[FEMA5:Low-grade_serous_carcinoma_of_the_peritoneum|Low-grade serous carcinoma of the peritoneum]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[FEMA5:High-grade_serous_carcinoma_of_the_peritoneum|High-grade serous carcinoma of the peritoneum]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[FEMA5:_Leiomyomatosis_peritonealis_disseminata_| Leiomyomatosis peritonealis disseminata]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[FEMA5:Desmoid_fibromatosis|Desmoid fibromatosis]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[FEMA5:Calcifying_fibrous_tumour_|Calcifying fibrous tumour]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[FEMA5:Extragastrointestinal_stromal_tumour|Extragastrointestinal stromal tumour]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[FEMA5:Solitary_fibrous_tumour_of_the_peritoneum|Solitary fibrous tumour of the peritoneum]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[FEMA5:Endometrioid_stromal_sarcoma_of_the_peritoneum|Endometrioid stromal sarcoma of the peritoneum]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[FEMA5:Desmoplastic_small_round_cell_tumour|Desmoplastic small round cell tumour]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[FEMA5:Mesothelial_hyperplasia|Mesothelial hyperplasia]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[FEMA5:Peritoneal_inclusion_cysts_|Peritoneal inclusion cysts]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[FEMA5:Transitional_cell_metaplasia|Transitional cell metaplasia]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[FEMA5:Endosalpingiosis_of_the_peritoneum|Endosalpingiosis of the peritoneum]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[FEMA5:Histiocytic_nodule|Histiocytic nodule]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[FEMA5:Ectopic_decidua|Ectopic decidua]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[FEMA5:Splenosis|Splenosis]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[FEMA5:Other_tumour-like_lesions_of_the_peritoneum|Other tumour-like lesions of the peritoneum]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[FEMA5:Carcinomas_and_sarcomas_metastatic_to_the_peritoneum|Carcinomas and sarcomas metastatic to the peritoneum]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[FEMA5:Pseudomyxoma_peritonei|Pseudomyxoma peritonei]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[FEMA5:Gliomatosis|Gliomatosis]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|
 +
==== CHAPTER 5 (TUMOURS OF THE FALLOPIAN TUBE) ====
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 +
|-
 +
|[[FEMA5:Serous_adenofibroma_and_papilloma_of_the_fallopian_tube|Serous adenofibroma and papilloma of the fallopian tube]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[FEMA5:Serous_borderline_tumour_of_the_fallopian_tube|Serous borderline tumour of the fallopian tube]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[FEMA5:High-grade_serous_carcinoma_of_the_fallopian_tube|High-grade serous carcinoma of the fallopian tube]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[FEMA5:Endometrioid_carcinoma_of_the_fallopian_tube|Endometrioid carcinoma of the fallopian tube]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[FEMA5:Carcinosarcoma_of_the_fallopian_tube|Carcinosarcoma of the fallopian tube]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[FEMA5:Paratubal_cysts|Paratubal cysts]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[FEMA5:Tubal_hyperplasia|Tubal hyperplasia]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[FEMA5:Tubo-ovarian_abscess|Tubo-ovarian abscess]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[FEMA5:Salpingitis_isthmica_nodosa|Salpingitis isthmica nodosa]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[FEMA5:Metaplastic_papillary_lesion|Metaplastic papillary lesion]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[FEMA5:Placental_site_nodule_occurring_in_the_fallopian_tube|Placental site nodule occurring in the fallopian tube]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[FEMA5:Mucinous_metaplasia|Mucinous metaplasia]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[FEMA5:Adenosarcoma_of_the_fallopian_tube|Adenosarcoma of the fallopian tube]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[FEMA5:Teratoma_of_the_fallopian_tube|Teratoma of the fallopian tube]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|
 +
==== CHAPTER 6 (TUMOURS OF THE BROAD LIGAMENT AND OTHER UTERINE LIGAMENTS) ====
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 +
|-
 +
|[[FEMA5:Leiomyoma_of_the_broad_ligament_and_other_uterine_ligaments|Leiomyoma of the broad ligament and other uterine ligaments]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[FEMA5:Adenomyoma_of_the_broad_ligament_and_other_uterine_ligaments|Adenomyoma of the broad ligament and other uterine ligaments]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[FEMA5:Adenosarcoma_of_the_broad_ligament_and_other_uterine_ligaments|Adenosarcoma of the broad ligament and other uterine ligaments]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[FEMA5:Leiomyosarcoma_of_the_broad_ligament_and_other_uterine_ligaments|Leiomyosarcoma of the broad ligament and other uterine ligaments]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[FEMA5:Wolffian_tumour_of_the_broad_ligament_and_other_uterine_ligaments|Wolffian tumour of the broad ligament and other uterine ligaments]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[FEMA5:Papillary_cystadenoma_|Papillary cystadenoma]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[FEMA5:Ependymoma_|Ependymoma]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[FEMA5:Adrenocortical_remnants|Adrenocortical remnants]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|
 +
==== CHAPTER 7 (TUMOURS OF THE UTERINE CORPUS) ====
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 +
|-
 +
|[[FEMA5:Endometrial_hyperplasia_without_atypia|Endometrial hyperplasia without atypia]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[FEMA5:Endometrial_atypical_hyperplasia_/_endometrioid_intraepithelial_neoplasia|Endometrial atypical hyperplasia / endometrioid intraepithelial neoplasia]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[FEMA5:Endometrioid_carcinoma_of_the_uterine_corpus|Endometrioid carcinoma of the uterine corpus]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 
|-
 
|-
−
| ||Disease||
+
|[[FEMA5:Serous_carcinoma_of_the_uterine_corpus|Serous carcinoma of the uterine corpus]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 27: Line 1,476:
 
|
 
|
 
|-
 
|-
−
| ||Disease||
+
|[[FEMA5:Clear_cell_carcinoma_of_the_uterine_corpus_|Clear cell carcinoma of the uterine corpus]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 36: Line 1,487:
 
|
 
|
 
|-
 
|-
−
| ||Disease||
+
|[[FEMA5:Undifferentiated_and_dedifferentiated_carcinomas_of_the_uterine_corpus|Undifferentiated and dedifferentiated carcinomas of the uterine corpus]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 45: Line 1,498:
 
|
 
|
 
|-
 
|-
−
| ||Disease||
+
|[[FEMA5:Mixed_carcinoma_of_the_uterine_corpus|Mixed carcinoma of the uterine corpus]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 54: Line 1,509:
 
|
 
|
 
|-
 
|-
−
| ||Disease||
+
|[[FEMA5:Other_endometrial_carcinomas|Other endometrial carcinomas]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 63: Line 1,520:
 
|
 
|
 
|-
 
|-
−
| ||Disease||
+
|[[FEMA5:Carcinosarcoma_of_the_uterine_corpus|Carcinosarcoma of the uterine corpus]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 72: Line 1,531:
 
|
 
|
 
|-
 
|-
−
| ||Disease||
+
|[[FEMA5:Endometrial_polyp|Endometrial polyp]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 81: Line 1,542:
 
|
 
|
 
|-
 
|-
−
| ||Disease||
+
|[[FEMA5:Endometrial_metaplasia|Endometrial metaplasia]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 90: Line 1,553:
 
|
 
|
 
|-
 
|-
−
| ||Disease||
+
|[[FEMA5:Arias-Stella_reaction_of_the_uterine_corpus|Arias-Stella reaction of the uterine corpus]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 99: Line 1,564:
 
|
 
|
 
|-
 
|-
−
| ||Disease||
+
|[[FEMA5:Uterine_leiomyoma|Uterine leiomyoma]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 108: Line 1,575:
 
|
 
|
 
|-
 
|-
−
| ||Disease||
+
|[[FEMA5:Intravenous_leiomyomatosis_|Intravenous leiomyomatosis]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 117: Line 1,586:
 
|
 
|
 
|-
 
|-
−
| ||Disease||
+
|[[FEMA5:Smooth_muscle_tumour_of_uncertain_malignant_potential_of_the_uterine_corpus|Smooth muscle tumour of uncertain malignant potential of the uterine corpus]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 126: Line 1,597:
 
|
 
|
 
|-
 
|-
−
| ||Disease||
+
|[[FEMA5:Metastasizing_leiomyoma_|Metastasizing leiomyoma]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 135: Line 1,608:
 
|
 
|
 
|-
 
|-
−
| ||Disease||
+
|[[FEMA5:Uterine_leiomyosarcoma_|Uterine leiomyosarcoma]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 144: Line 1,619:
 
|
 
|
 
|-
 
|-
−
| ||Disease||
+
|[[FEMA5:Endometrial_stromal_nodule_|Endometrial stromal nodule]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 153: Line 1,630:
 
|
 
|
 
|-
 
|-
−
| ||Disease||
+
|[[FEMA5:Low-grade_endometrial_stromal_sarcoma_|Low-grade endometrial stromal sarcoma]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 162: Line 1,641:
 
|
 
|
 
|-
 
|-
−
| ||Disease||
+
|[[FEMA5:High-grade_endometrial_stromal_sarcoma_|High-grade endometrial stromal sarcoma]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 171: Line 1,652:
 
|
 
|
 
|-
 
|-
−
| ||Disease||
+
|[[FEMA5:Undifferentiated_uterine_sarcoma_|Undifferentiated uterine sarcoma]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 180: Line 1,663:
 
|
 
|
 
|-
 
|-
−
| ||Disease||
+
|[[FEMA5:Uterine_tumour_resembling_ovarian_sex_cord_tumour_|Uterine tumour resembling ovarian sex cord tumour]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 189: Line 1,674:
 
|
 
|
 
|-
 
|-
−
| ||Disease||
+
|[[FEMA5:Perivascular_epithelioid_cell_tumour_(PEComa)|Perivascular epithelioid cell tumour (PEComa)]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 198: Line 1,685:
 
|
 
|
 
|-
 
|-
−
| ||Disease||
+
|[[FEMA5:Inflammatory_myofibroblastic_tumour|Inflammatory myofibroblastic tumour]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 207: Line 1,696:
 
|
 
|
 
|-
 
|-
−
| ||Disease||
+
|[[FEMA5:Adenomyoma_of_the_uterine_corpus|Adenomyoma of the uterine corpus]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 216: Line 1,707:
 
|
 
|
 
|-
 
|-
−
| ||Disease||
+
|[[FEMA5:Atypical_polypoid_adenomyoma_|Atypical polypoid adenomyoma]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 225: Line 1,718:
 
|
 
|
 
|-
 
|-
−
| ||Disease||
+
|[[FEMA5:Adenosarcoma_of_the_uterine_corpus|Adenosarcoma of the uterine corpus]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 234: Line 1,729:
 
|
 
|
 
|-
 
|-
−
| ||Disease||
+
|[[FEMA5:Central_primitive_neuroectodermal_tumour_/_CNS_embryonal_tumour|Central primitive neuroectodermal tumour / CNS embryonal tumour]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 243: Line 1,740:
 
|
 
|
 
|-
 
|-
−
| ||Disease||
+
|[[FEMA5:Germ_cell_tumours_of_the_uterine_corpus|Germ cell tumours of the uterine corpus]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 252: Line 1,751:
 
|
 
|
 
|-
 
|-
−
| ||Disease||
 
 
|
 
|
 +
==== CHAPTER 8 (GESTATIONAL TROPHOBLASTIC DISEASE) ====
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 
|
 
|
 +
----
 
|
 
|
 +
----
 
|
 
|
 +
----
 
|
 
|
 +
----
 
|
 
|
 +
----
 
|
 
|
 +
----
 
|-
 
|-
−
| ||Disease||
+
|[[FEMA5:Exaggerated_placental_site_reaction|Exaggerated placental site reaction]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 270: Line 1,783:
 
|
 
|
 
|-
 
|-
−
| ||Disease||
+
|[[FEMA5:Placental_site_nodule_and_plaque|Placental site nodule and plaque]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 279: Line 1,794:
 
|
 
|
 
|-
 
|-
−
| ||Disease||
+
|[[FEMA5:Abnormal_(non-molar)_villous_lesions|Abnormal (non-molar) villous lesions]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 288: Line 1,805:
 
|
 
|
 
|-
 
|-
−
| ||Disease||
+
|[[FEMA5:Partial_hydatidiform_mole|Partial hydatidiform mole]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 297: Line 1,816:
 
|
 
|
 
|-
 
|-
−
| ||Disease||
+
|[[FEMA5:Complete_hydatidiform_mole|Complete hydatidiform mole]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 306: Line 1,827:
 
|
 
|
 
|-
 
|-
−
| ||Disease||
+
|[[FEMA5:Invasive_and_metastatic_hydatidiform_moles|Invasive and metastatic hydatidiform moles]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 315: Line 1,838:
 
|
 
|
 
|-
 
|-
−
| ||Disease||
+
|[[FEMA5:Epithelioid_trophoblastic_tumour_|Epithelioid trophoblastic tumour]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 324: Line 1,849:
 
|
 
|
 
|-
 
|-
−
| ||Disease||
+
|[[FEMA5:Placental_site_trophoblastic_tumour_|Placental site trophoblastic tumour]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 333: Line 1,860:
 
|
 
|
 
|-
 
|-
−
| ||Disease||
+
|[[FEMA5:Gestational_choriocarcinoma|Gestational choriocarcinoma]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 342: Line 1,871:
 
|
 
|
 
|-
 
|-
−
| ||Disease||
+
|[[FEMA5:Mixed_trophoblastic_tumour|Mixed trophoblastic tumour]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 351: Line 1,882:
 
|
 
|
 
|-
 
|-
−
| ||Disease||
 
 
|
 
|
 +
==== CHAPTER 9 (TUMOURS OF THE UTERINE CERVIX) ====
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 
|
 
|
 +
----
 
|
 
|
 +
----
 
|
 
|
 +
----
 
|
 
|
 +
----
 
|
 
|
 +
----
 
|
 
|
 +
----
 
|-
 
|-
−
| ||Disease||
+
|[[FEMA5:Squamous_metaplasia|Squamous metaplasia]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 369: Line 1,914:
 
|
 
|
 
|-
 
|-
−
| ||Disease||
+
|[[FEMA5:Atrophy_of_the_uterine_cervix|Atrophy of the uterine cervix]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 378: Line 1,925:
 
|
 
|
 
|-
 
|-
−
| ||Disease||
+
|[[FEMA5:Squamous_intraepithelial_lesions_of_the_uterine_cervix|Squamous intraepithelial lesions of the uterine cervix]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 387: Line 1,936:
 
|
 
|
 
|-
 
|-
−
| ||Disease||
+
|[[FEMA5:Squamous_cell_carcinoma,_HPV-associated,_of_the_uterine_cervix|Squamous cell carcinoma, HPV-associated, of the uterine cervix]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 396: Line 1,947:
 
|
 
|
 
|-
 
|-
−
| ||Disease||
+
|[[FEMA5:Squamous_cell_carcinoma,_HPV-independent,_of_the_uterine_cervix|Squamous cell carcinoma, HPV-independent, of the uterine cervix]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 405: Line 1,958:
 
|
 
|
 
|-
 
|-
−
| ||Disease||
+
|[[FEMA5:Endocervical_polyp|Endocervical polyp]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 414: Line 1,969:
 
|
 
|
 
|-
 
|-
−
| ||Disease||
+
|[[FEMA5:Mullerian_papilloma_of_the_uterine_cervix|Mullerian papilloma of the uterine cervix]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 423: Line 1,980:
 
|
 
|
 
|-
 
|-
−
| ||Disease||
+
|[[FEMA5:Nabothian_cyst|Nabothian cyst]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 432: Line 1,991:
 
|
 
|
 
|-
 
|-
−
| ||Disease||
+
|[[FEMA5:Tunnel_clusters|Tunnel clusters]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 441: Line 2,002:
 
|
 
|
 
|-
 
|-
−
| ||Disease||
+
|[[FEMA5:Microglandular_hyperplasia|Microglandular hyperplasia]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 450: Line 2,013:
 
|
 
|
 
|-
 
|-
−
| ||Disease||
+
|[[FEMA5:Lobular_endocervical_glandular_hyperplasia|Lobular endocervical glandular hyperplasia]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 459: Line 2,024:
 
|
 
|
 
|-
 
|-
−
| ||Disease||
+
|[[FEMA5:Diffuse_laminar_endocervical_hyperplasia|Diffuse laminar endocervical hyperplasia]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 468: Line 2,035:
 
|
 
|
 
|-
 
|-
−
| ||Disease||
+
|[[FEMA5:Mesonephric_remnants_and_hyperplasia|Mesonephric remnants and hyperplasia]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 477: Line 2,046:
 
|
 
|
 
|-
 
|-
−
| ||Disease||
+
|[[FEMA5:Arias-Stella_reaction_of_the_uterine_cervix|Arias-Stella reaction of the uterine cervix]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 486: Line 2,057:
 
|
 
|
 
|-
 
|-
−
| ||Disease||
+
|[[FEMA5:Endocervicosis_of_the_uterine_cervix|Endocervicosis of the uterine cervix]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 495: Line 2,068:
 
|
 
|
 
|-
 
|-
−
| ||Disease||
+
|[[FEMA5:Tuboendometrioid_metaplasia|Tuboendometrioid metaplasia]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 504: Line 2,079:
 
|
 
|
 
|-
 
|-
−
| ||Disease||
+
|[[FEMA5:Ectopic_prostate_tissue|Ectopic prostate tissue]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 513: Line 2,090:
 
|
 
|
 
|-
 
|-
−
| ||Disease||
+
|[[FEMA5:Adenocarcinoma_in_situ,_HPV-associated,_of_the_uterine_cervix|Adenocarcinoma in situ, HPV-associated, of the uterine cervix]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 522: Line 2,101:
 
|
 
|
 
|-
 
|-
−
| ||Disease||
+
|[[FEMA5:Adenocarcinoma,_HPV-associated,_of_the_uterine_cervix|Adenocarcinoma, HPV-associated, of the uterine cervix]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 531: Line 2,112:
 
|
 
|
 
|-
 
|-
−
| ||Disease||
+
|[[FEMA5:Adenocarcinoma_in_situ,_HPV-independent,_of_the_uterine_cervix|Adenocarcinoma in situ, HPV-independent, of the uterine cervix]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 540: Line 2,123:
 
|
 
|
 
|-
 
|-
−
| ||Disease||
+
|[[FEMA5:Adenocarcinoma,_HPV-independent,_gastric_type,_of_the_uterine_cervix|Adenocarcinoma, HPV-independent, gastric type, of the uterine cervix]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 549: Line 2,134:
 
|
 
|
 
|-
 
|-
−
| ||Disease||
+
|[[FEMA5:Adenocarcinoma,_HPV-independent,_clear_cell_type,_of_the_uterine_cervix|Adenocarcinoma, HPV-independent, clear cell type, of the uterine cervix]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 558: Line 2,145:
 
|
 
|
 
|-
 
|-
−
| ||Disease||
+
|[[FEMA5:Adenocarcinoma,_HPV-independent,_mesonephric_type,_of_the_uterine_cervix|Adenocarcinoma, HPV-independent, mesonephric type, of the uterine cervix]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 567: Line 2,156:
 
|
 
|
 
|-
 
|-
−
| ||Disease||
+
|[[FEMA5:Other_adenocarcinomas_of_the_uterine_cervix|Other adenocarcinomas of the uterine cervix]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 576: Line 2,167:
 
|
 
|
 
|-
 
|-
−
| ||Disease||
+
|[[FEMA5:Carcinosarcoma_of_the_uterine_cervix|Carcinosarcoma of the uterine cervix]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 585: Line 2,178:
 
|
 
|
 
|-
 
|-
−
| ||Disease||
+
|[[FEMA5:Adenosquamous_and_mucoepidermoid_carcinomas_of_the_uterine_cervix|Adenosquamous and mucoepidermoid carcinomas of the uterine cervix]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 594: Line 2,189:
 
|
 
|
 
|-
 
|-
−
| ||Disease||
+
|[[FEMA5:Adenoid_basal_carcinoma_of_the_uterine_cervix|Adenoid basal carcinoma of the uterine cervix]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 603: Line 2,200:
 
|
 
|
 
|-
 
|-
−
| ||Disease||
+
|[[FEMA5:Carcinoma_of_the_uterine_cervix,_unclassifiable|Carcinoma of the uterine cervix, unclassifiable]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 612: Line 2,211:
 
|
 
|
 
|-
 
|-
−
| ||Disease||
+
|[[FEMA5:Adenomyoma_of_the_uterine_cervix|Adenomyoma of the uterine cervix]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 621: Line 2,222:
 
|
 
|
 
|-
 
|-
−
| ||Disease||
+
|[[FEMA5:Adenosarcoma_of_the_uterine_cervix|Adenosarcoma of the uterine cervix]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 630: Line 2,233:
 
|
 
|
 
|-
 
|-
−
| ||Disease||
+
|[[FEMA5:Germ_cell_tumours_of_the_uterine_cervix|Germ cell tumours of the uterine cervix]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 639: Line 2,244:
 
|
 
|
 
|-
 
|-
−
| ||Disease||
 
 
|
 
|
 +
==== CHAPTER 10 (TUMOURS OF THE VAGINA) ====
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 
|
 
|
 +
----
 
|
 
|
 +
----
 
|
 
|
 +
----
 
|
 
|
 +
----
 
|
 
|
 +
----
 
|
 
|
 +
----
 
|-
 
|-
−
| ||Disease||
+
|[[FEMA5:Squamous_papilloma_of_the_vagina|Squamous papilloma of the vagina]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 657: Line 2,276:
 
|
 
|
 
|-
 
|-
−
| ||Disease||
+
|[[FEMA5:Atrophy_of_the_vagina|Atrophy of the vagina]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 666: Line 2,287:
 
|
 
|
 
|-
 
|-
−
| ||Disease||
+
|[[FEMA5:Tubulosquamous_polyp_|Tubulosquamous polyp]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 675: Line 2,298:
 
|
 
|
 
|-
 
|-
−
| ||Disease||
+
|[[FEMA5:Squamous_intraepithelial_lesions_of_the_vagina|Squamous intraepithelial lesions of the vagina]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 684: Line 2,309:
 
|
 
|
 
|-
 
|-
−
| ||Disease||
+
|[[FEMA5:Squamous_cell_carcinoma,_HPV-associated,_of_the_vagina|Squamous cell carcinoma, HPV-associated, of the vagina]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 693: Line 2,320:
 
|
 
|
 
|-
 
|-
−
| ||Disease||
+
|[[FEMA5:Squamous_cell_carcinoma,_HPV-independent,_of_the_vagina|Squamous cell carcinoma, HPV-independent, of the vagina]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 702: Line 2,331:
 
|
 
|
 
|-
 
|-
−
| ||Disease||
+
|[[FEMA5:Villous_adenoma_|Villous adenoma]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 711: Line 2,342:
 
|
 
|
 
|-
 
|-
−
| ||Disease||
+
|[[FEMA5:Mullerian_papilloma_of_the_vagina|Mullerian papilloma of the vagina]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 720: Line 2,353:
 
|
 
|
 
|-
 
|-
−
| ||Disease||
+
|[[FEMA5:Vaginal_adenosis|Vaginal adenosis]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 729: Line 2,364:
 
|
 
|
 
|-
 
|-
−
| ||Disease||
+
|[[FEMA5:Endocervicosis_of_the_vagina|Endocervicosis of the vagina]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 738: Line 2,375:
 
|
 
|
 
|-
 
|-
 +
|[[FEMA5:Cysts_of_the_vagina|Cysts of the vagina]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 
|
 
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[FEMA5:Adenocarcinoma,_HPV-associated,_of_the_vagina|Adenocarcinoma, HPV-associated, of the vagina]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[FEMA5:Endometrioid_carcinoma_of_the_vagina|Endometrioid carcinoma of the vagina]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[FEMA5:Clear_cell_carcinoma_of_the_vagina|Clear cell carcinoma of the vagina]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[FEMA5:Mucinous_carcinoma,_gastric_type,_of_the_vagina|Mucinous carcinoma, gastric type, of the vagina]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[FEMA5:Mucinous_carcinoma,_intestinal_type,_of_the_vagina|Mucinous carcinoma, intestinal type, of the vagina]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[FEMA5:Mesonephric_adenocarcinoma_of_the_vagina|Mesonephric adenocarcinoma of the vagina]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[FEMA5:Carcinosarcoma_of_the_vagina|Carcinosarcoma of the vagina]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[FEMA5:Mixed_tumour_of_the_vagina|Mixed tumour of the vagina]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[FEMA5:Adenocarcinoma_of_Skene_gland_origin_|Adenocarcinoma of Skene gland origin]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[FEMA5:Adenosquamous_carcinoma_of_the_vagina|Adenosquamous carcinoma of the vagina]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[FEMA5:Adenosarcoma_of_the_vagina_|Adenosarcoma of the vagina]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[FEMA5:Germ_cell_tumours_of_the_vagina|Germ cell tumours of the vagina]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|
 +
==== CHAPTER 11 (TUMOURS OF THE VULVA) ====
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 +
|-
 +
|[[FEMA5:Seborrhoeic_keratosis|Seborrhoeic keratosis]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[FEMA5:Condyloma_acuminatum|Condyloma acuminatum]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[FEMA5:Squamous_intraepithelial_lesions,_HPV-associated,_of_the_vulva|Squamous intraepithelial lesions, HPV-associated, of the vulva]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[FEMA5:Vulvar_intraepithelial_neoplasia,_HPV-independent|Vulvar intraepithelial neoplasia, HPV-independent]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[FEMA5:Squamous_cell_carcinoma,_HPV-associated,_of_the_vulva|Squamous cell carcinoma, HPV-associated, of the vulva]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[FEMA5:Squamous_cell_carcinoma,_HPV-independent,_of_the_vulva|Squamous cell carcinoma, HPV-independent, of the vulva]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[FEMA5:Papillary_hidradenoma_|Papillary hidradenoma]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[FEMA5:Chondroid_syringoma|Chondroid syringoma]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[FEMA5:Fibroadenoma_|Fibroadenoma]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[FEMA5:Phyllodes_tumour|Phyllodes tumour]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[FEMA5:Adenocarcinoma_of_mammary_gland_type_|Adenocarcinoma of mammary gland type]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[FEMA5:Bartholin_gland_cyst|Bartholin gland cyst]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[FEMA5:Bartholin_gland_hyperplasia,_adenoma,_and_adenomyoma|Bartholin gland hyperplasia, adenoma, and adenomyoma]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[FEMA5:Bartholin_gland_carcinomas|Bartholin gland carcinomas]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[FEMA5:Other_cysts_of_the_vulva|Other cysts of the vulva]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[FEMA5:Paget_disease_|Paget disease]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[FEMA5:Carcinomas_of_sweat_gland_origin|Carcinomas of sweat gland origin]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[FEMA5:Adenocarcinoma_of_intestinal_type_|Adenocarcinoma of intestinal type]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[FEMA5:Germ_cell_tumours_of_the_vulva|Germ cell tumours of the vulva]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|
 +
==== CHAPTER 12 (NEUROENDOCRINE NEOPLASIA) ====
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 +
|-
 +
|[[FEMA5:Neuroendocrine_tumour|Neuroendocrine tumour]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[FEMA5:Small_cell_neuroendocrine_carcinoma|Small cell neuroendocrine carcinoma]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[FEMA5:Large_cell_neuroendocrine_carcinoma|Large cell neuroendocrine carcinoma]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[FEMA5:Carcinoma_admixed_with_neuroendocrine_carcinoma_|Carcinoma admixed with neuroendocrine carcinoma]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|
 +
==== CHAPTER 13 (HAEMATOLYMPHOID PROLIFERATIONS AND NEOPLASIA) ====
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 +
|-
 +
|[[FEMA5:Florid_reactive_lymphoid_hyperplasia|Florid reactive lymphoid hyperplasia]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[FEMA5:Diffuse_large_B-cell_lymphoma|Diffuse large B-cell lymphoma]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[FEMA5:Extranodal_marginal_zone_lymphoma|Extranodal marginal zone lymphoma]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[FEMA5:Follicular_lymphoma|Follicular lymphoma]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[FEMA5:Burkitt_lymphoma|Burkitt lymphoma]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[FEMA5:Myeloid_sarcoma|Myeloid sarcoma]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|
 +
==== CHAPTER 14 (MESENCHYMAL TUMOURS OF THE LOWER GENITAL TRACT) ====
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 +
|-
 +
|[[FEMA5:Lipoma_|Lipoma]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[FEMA5:Lipoblastoma-like_tumour_of_the_vulva|Lipoblastoma-like tumour of the vulva]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[FEMA5:Liposarcoma_|Liposarcoma]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[FEMA5:Postoperative_spindle_cell_nodule|Postoperative spindle cell nodule]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[FEMA5:Fibroepithelial_stromal_polyp|Fibroepithelial stromal polyp]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[FEMA5:Prepubertal_fibroma|Prepubertal fibroma]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[FEMA5:Superficial_myofibroblastoma_|Superficial myofibroblastoma]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[FEMA5:Myofibroblastoma_|Myofibroblastoma]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[FEMA5:Cellular_angiofibroma_|Cellular angiofibroma]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[FEMA5:Angiomyofibroblastoma_|Angiomyofibroblastoma]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[FEMA5:Solitary_fibrous_tumour_of_the_lower_genital_tract|Solitary fibrous tumour of the lower genital tract]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[FEMA5:Dermatofibrosarcoma_protuberans_|Dermatofibrosarcoma protuberans]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[FEMA5:NTRK-rearranged_spindle_cell_neoplasm_(emerging)|NTRK-rearranged spindle cell neoplasm (emerging)]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[FEMA5:Kaposi_sarcoma_|Kaposi sarcoma]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[FEMA5:Angiosarcoma_|Angiosarcoma]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[FEMA5:Leiomyoma_of_the_lower_genital_tract|Leiomyoma of the lower genital tract]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[FEMA5:Smooth_muscle_tumour_of_uncertain_malignant_potential_of_the_lower_genital_tract|Smooth muscle tumour of uncertain malignant potential of the lower genital tract]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[FEMA5:Leiomyosarcoma_of_the_lower_genital_tract|Leiomyosarcoma of the lower genital tract]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[FEMA5:Rhabdomyoma_|Rhabdomyoma]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[FEMA5:Rhabdomyosarcoma|Rhabdomyosarcoma]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[FEMA5:Benign_peripheral_nerve_sheath_tumours|Benign peripheral nerve sheath tumours]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[FEMA5:Granular_cell_tumour_|Granular cell tumour]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[FEMA5:Superficial_angiomyxoma_|Superficial angiomyxoma]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[FEMA5:Deep_(aggressive)_angiomyxoma_|Deep (aggressive) angiomyxoma]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[FEMA5:Epithelioid_sarcoma_|Epithelioid sarcoma]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[FEMA5:Alveolar_soft_part_sarcoma_|Alveolar soft part sarcoma]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[FEMA5:Ewing_sarcoma_|Ewing sarcoma]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|
 +
==== CHAPTER 15 (MELANOCYTIC LESIONS) ====
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 +
|-
 +
|[[FEMA5:Acquired_melanocytic_naevus|Acquired melanocytic naevus]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[FEMA5:Congenital_melanocytic_naevus_|Congenital melanocytic naevus]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[FEMA5:Blue_naevus_|Blue naevus]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[FEMA5:Atypical_melanocytic_naevus_of_genital_type_|Atypical melanocytic naevus of genital type]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[FEMA5:Dysplastic_melanocytic_naevus_|Dysplastic melanocytic naevus]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[FEMA5:Mucosal_melanoma_|Mucosal melanoma]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|
 +
==== CHAPTER 16 (METASTASIS) ====
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 +
|-
 +
|[[FEMA5:Metastasis_to_the_lower_female_genital_tract|Metastasis to the lower female genital tract]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|
 +
==== CHAPTER 17 (GENETIC TUMOUR SYNDROMES OF THE FEMALE GENITAL TRACT) ====
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 +
|-
 +
|[[FEMA5:BRCA1/2-associated_hereditary_breast_and_ovarian_cancer_syndrome|BRCA1/2-associated hereditary breast and ovarian cancer syndrome]]
 +
|Disease
 +
|[[GTS5:Volunteer Assignments and Opportunities|See GTS5 volunteer sheet for authorship  status]]
 +
|N/A
 +
|N/A
 +
|N/A
 +
|N/A
 +
|N/A
 +
|N/A
 +
|N/A
 +
|-
 +
|[[FEMA5:Lynch_syndrome|Lynch syndrome]]
 +
|Disease
 +
|[[GTS5:Volunteer Assignments and Opportunities|See GTS5 volunteer sheet for authorship status]]
 +
|N/A
 +
|N/A
 +
|N/A
 +
|N/A
 +
|N/A
 +
|N/A
 +
|N/A
 +
|-
 +
|[[FEMA5:Cowden_syndrome|Cowden syndrome]]
 +
|Disease
 +
|[[DIG5:Volunteer Assignments and Opportunities|See DIG5 volunteer sheet for authorship status]]
 +
|N/A
 +
|N/A
 +
|N/A
 +
|N/A
 +
|N/A
 +
|N/A
 +
|N/A
 +
|-
 +
|[[FEMA5:Li-Fraumeni_syndrome|Li-Fraumeni syndrome]]
 +
|Disease
 +
|[[GTS5:Volunteer Assignments and Opportunities|See GTS5 volunteer sheet for authorship  status]]
 +
|N/A
 +
|N/A
 +
|N/A
 +
|N/A
 +
|N/A
 +
|N/A
 +
|N/A
 +
|-
 +
|[[FEMA5:Peutz-Jeghers_syndrome|Peutz-Jeghers syndrome]]
 +
|Disease
 +
|[[GTS5:Volunteer Assignments and Opportunities|See GTS5 volunteer sheet for authorship  status]]
 +
|N/A
 +
|N/A
 +
|N/A
 +
|N/A
 +
|N/A
 +
|N/A
 +
|N/A
 +
|-
 +
|[[FEMA5:Ataxia-telangiectasia|Ataxia-telangiectasia]]
 +
|Disease
 +
|[[GTS5:Volunteer Assignments and Opportunities|See GTS5 volunteer sheet for authorship  status]]
 +
|N/A
 +
|N/A
 +
|N/A
 +
|N/A
 +
|N/A
 +
|N/A
 +
|N/A
 +
|-
 +
|[[FEMA5:Carney_complex|Carney complex]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[FEMA5:DICER1_syndrome_|DICER1 syndrome]]
 +
|Disease
 +
|[[GTS5:Volunteer Assignments and Opportunities|See GTS5 volunteer sheet for authorship  status]]
 +
|N/A
 +
|N/A
 +
|N/A
 +
|N/A
 +
|N/A
 +
|N/A
 +
|N/A
 +
|-
 +
|[[FEMA5:Ovarian_dysgenesis|Ovarian dysgenesis]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[FEMA5:Von_Hippel-Lindau_syndrome|Von Hippel-Lindau syndrome]]
 +
|Disease
 +
|[[GTS5:Volunteer Assignments and Opportunities|See GTS5 volunteer sheet for authorship  status]]
 +
|N/A
 +
|N/A
 +
|N/A
 +
|N/A
 +
|N/A
 +
|N/A
 +
|N/A
 +
|-
 +
|[[FEMA5:Hereditary_leiomyomatosis_and_renal_cell_carcinoma|Hereditary leiomyomatosis and renal cell carcinoma]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[FEMA5:Other genetic tumour syndromes of the female genital tract|Other genetic tumour syndromes of the female genital tract]]
 
|Disease
 
|Disease
 
|
 
|

Latest revision as of 14:14, 10 September 2024

Welcome!

For assignments, please see the "Author" column below (highlighted blue).

If empty (no name is present), please volunteer to create content for that disease!

To volunteer, please [Contact us] with your page of interest.

WHO Classification of Female Genital Tumours (5th Edition) Content
Disease Page Type Author Date Assigned to Author Target Completion Date Author Content (Pending or Complete) Date Completed by Author Associate Editor Date of Last Editor Review Notes

CHAPTER 2 (TUMOURS OF THE OVARY)
Serous cystadenoma, adenofibroma, and surface papilloma of the ovary Disease
Serous borderline tumour of the ovary Disease
Low-grade serous carcinoma of the ovary Disease
High-grade serous carcinoma of the ovary Disease
Mucinous cystadenoma and adenofibroma Disease
Mucinous borderline tumour Disease
Mucinous carcinoma of the ovary Disease
Endometrioid cystadenoma and adenofibroma Disease
Endometrioid borderline tumour Disease
Endometrioid carcinoma of the ovary Disease
Clear cell cystadenoma and adenofibroma Disease
Clear cell borderline tumour Disease
Clear cell carcinoma of the ovary Disease
Seromucinous cystadenoma and adenofibroma Disease
Seromucinous borderline tumour Disease
Brenner tumour Disease
Borderline Brenner tumour Disease
Malignant Brenner tumour Disease
Mesonephric-like adenocarcinoma Disease
Undifferentiated and dedifferentiated carcinomas of the ovary Disease
Carcinosarcoma of the ovary Disease
Mixed carcinoma of the ovary Disease
Endometrioid stromal sarcoma of the ovary Disease
Smooth muscle tumours of the ovary Disease
Ovarian myxoma Disease
Adenosarcoma of the ovary Disease
Ovarian fibroma Disease
Thecoma Disease
Luteinized thecoma associated with sclerosing peritonitis Disease
Sclerosing stromal tumour Disease
Microcystic stromal tumour Disease
Signet-ring stromal tumour Disease
Leydig cell tumour Disease
Steroid cell tumour Disease
Ovarian fibrosarcoma Disease
Adult granulosa cell tumour Disease
Juvenile granulosa cell tumour Disease
Sertoli cell tumour Disease
Sex cord tumour with annular tubules Disease
Sertoli-Leydig cell tumour Disease
Sex cord-stromal tumour NOS Disease
Gynandroblastoma Disease
Mature teratoma of the ovary Disease
Immature teratoma of the ovary Disease
Dysgerminoma Disease
Yolk sac tumour Disease
Embryonal carcinoma Disease
Non-gestational choriocarcinoma Disease
Mixed germ cell tumour of the ovary Disease
Struma ovarii Disease
Ovarian carcinoid Disease
Neuroectodermal-type tumours Disease
Monodermal cystic teratoma Disease
Somatic neoplasms arising from teratomas Disease
Gonadoblastoma Disease
Mixed germ cell-sex cord-stromal tumour, unclassified Disease
Rete cystadenoma, adenoma, and adenocarcinoma Disease
Wolffian tumour of the ovary Disease
Solid pseudopapillary tumour Disease
Small cell carcinoma of the ovary, hypercalcaemic type Disease
Wilms tumour Disease
Follicle cyst Disease
Corpus luteum cyst Disease
Large solitary luteinized follicle cyst Disease
Hyperreactio luteinalis Disease
Pregnancy luteoma Disease
Stromal hyperplasia and hyperthecosis Disease
Fibromatosis and massive oedema Disease
Leydig cell hyperplasia Disease
Metastases to the ovary Disease

CHAPTER 3 (ENDOMETRIOSIS AND RELATED CONDITIONS)
Endometriosis and derived tumours Disease

CHAPTER 4 (TUMOURS OF THE PERITONEUM)
Adenomatoid tumour Disease
Well-differentiated papillary mesothelial tumour Disease
Mesothelioma Disease
Serous borderline tumour of the peritoneum Disease
Low-grade serous carcinoma of the peritoneum Disease
High-grade serous carcinoma of the peritoneum Disease
Leiomyomatosis peritonealis disseminata Disease
Desmoid fibromatosis Disease
Calcifying fibrous tumour Disease
Extragastrointestinal stromal tumour Disease
Solitary fibrous tumour of the peritoneum Disease
Endometrioid stromal sarcoma of the peritoneum Disease
Desmoplastic small round cell tumour Disease
Mesothelial hyperplasia Disease
Peritoneal inclusion cysts Disease
Transitional cell metaplasia Disease
Endosalpingiosis of the peritoneum Disease
Histiocytic nodule Disease
Ectopic decidua Disease
Splenosis Disease
Other tumour-like lesions of the peritoneum Disease
Carcinomas and sarcomas metastatic to the peritoneum Disease
Pseudomyxoma peritonei Disease
Gliomatosis Disease

CHAPTER 5 (TUMOURS OF THE FALLOPIAN TUBE)
Serous adenofibroma and papilloma of the fallopian tube Disease
Serous borderline tumour of the fallopian tube Disease
High-grade serous carcinoma of the fallopian tube Disease
Endometrioid carcinoma of the fallopian tube Disease
Carcinosarcoma of the fallopian tube Disease
Paratubal cysts Disease
Tubal hyperplasia Disease
Tubo-ovarian abscess Disease
Salpingitis isthmica nodosa Disease
Metaplastic papillary lesion Disease
Placental site nodule occurring in the fallopian tube Disease
Mucinous metaplasia Disease
Adenosarcoma of the fallopian tube Disease
Teratoma of the fallopian tube Disease

CHAPTER 6 (TUMOURS OF THE BROAD LIGAMENT AND OTHER UTERINE LIGAMENTS)
Leiomyoma of the broad ligament and other uterine ligaments Disease
Adenomyoma of the broad ligament and other uterine ligaments Disease
Adenosarcoma of the broad ligament and other uterine ligaments Disease
Leiomyosarcoma of the broad ligament and other uterine ligaments Disease
Wolffian tumour of the broad ligament and other uterine ligaments Disease
Papillary cystadenoma Disease
Ependymoma Disease
Adrenocortical remnants Disease

CHAPTER 7 (TUMOURS OF THE UTERINE CORPUS)
Endometrial hyperplasia without atypia Disease
Endometrial atypical hyperplasia / endometrioid intraepithelial neoplasia Disease
Endometrioid carcinoma of the uterine corpus Disease
Serous carcinoma of the uterine corpus Disease
Clear cell carcinoma of the uterine corpus Disease
Undifferentiated and dedifferentiated carcinomas of the uterine corpus Disease
Mixed carcinoma of the uterine corpus Disease
Other endometrial carcinomas Disease
Carcinosarcoma of the uterine corpus Disease
Endometrial polyp Disease
Endometrial metaplasia Disease
Arias-Stella reaction of the uterine corpus Disease
Uterine leiomyoma Disease
Intravenous leiomyomatosis Disease
Smooth muscle tumour of uncertain malignant potential of the uterine corpus Disease
Metastasizing leiomyoma Disease
Uterine leiomyosarcoma Disease
Endometrial stromal nodule Disease
Low-grade endometrial stromal sarcoma Disease
High-grade endometrial stromal sarcoma Disease
Undifferentiated uterine sarcoma Disease
Uterine tumour resembling ovarian sex cord tumour Disease
Perivascular epithelioid cell tumour (PEComa) Disease
Inflammatory myofibroblastic tumour Disease
Adenomyoma of the uterine corpus Disease
Atypical polypoid adenomyoma Disease
Adenosarcoma of the uterine corpus Disease
Central primitive neuroectodermal tumour / CNS embryonal tumour Disease
Germ cell tumours of the uterine corpus Disease

CHAPTER 8 (GESTATIONAL TROPHOBLASTIC DISEASE)
Exaggerated placental site reaction Disease
Placental site nodule and plaque Disease
Abnormal (non-molar) villous lesions Disease
Partial hydatidiform mole Disease
Complete hydatidiform mole Disease
Invasive and metastatic hydatidiform moles Disease
Epithelioid trophoblastic tumour Disease
Placental site trophoblastic tumour Disease
Gestational choriocarcinoma Disease
Mixed trophoblastic tumour Disease

CHAPTER 9 (TUMOURS OF THE UTERINE CERVIX)
Squamous metaplasia Disease
Atrophy of the uterine cervix Disease
Squamous intraepithelial lesions of the uterine cervix Disease
Squamous cell carcinoma, HPV-associated, of the uterine cervix Disease
Squamous cell carcinoma, HPV-independent, of the uterine cervix Disease
Endocervical polyp Disease
Mullerian papilloma of the uterine cervix Disease
Nabothian cyst Disease
Tunnel clusters Disease
Microglandular hyperplasia Disease
Lobular endocervical glandular hyperplasia Disease
Diffuse laminar endocervical hyperplasia Disease
Mesonephric remnants and hyperplasia Disease
Arias-Stella reaction of the uterine cervix Disease
Endocervicosis of the uterine cervix Disease
Tuboendometrioid metaplasia Disease
Ectopic prostate tissue Disease
Adenocarcinoma in situ, HPV-associated, of the uterine cervix Disease
Adenocarcinoma, HPV-associated, of the uterine cervix Disease
Adenocarcinoma in situ, HPV-independent, of the uterine cervix Disease
Adenocarcinoma, HPV-independent, gastric type, of the uterine cervix Disease
Adenocarcinoma, HPV-independent, clear cell type, of the uterine cervix Disease
Adenocarcinoma, HPV-independent, mesonephric type, of the uterine cervix Disease
Other adenocarcinomas of the uterine cervix Disease
Carcinosarcoma of the uterine cervix Disease
Adenosquamous and mucoepidermoid carcinomas of the uterine cervix Disease
Adenoid basal carcinoma of the uterine cervix Disease
Carcinoma of the uterine cervix, unclassifiable Disease
Adenomyoma of the uterine cervix Disease
Adenosarcoma of the uterine cervix Disease
Germ cell tumours of the uterine cervix Disease

CHAPTER 10 (TUMOURS OF THE VAGINA)
Squamous papilloma of the vagina Disease
Atrophy of the vagina Disease
Tubulosquamous polyp Disease
Squamous intraepithelial lesions of the vagina Disease
Squamous cell carcinoma, HPV-associated, of the vagina Disease
Squamous cell carcinoma, HPV-independent, of the vagina Disease
Villous adenoma Disease
Mullerian papilloma of the vagina Disease
Vaginal adenosis Disease
Endocervicosis of the vagina Disease
Cysts of the vagina Disease
Adenocarcinoma, HPV-associated, of the vagina Disease
Endometrioid carcinoma of the vagina Disease
Clear cell carcinoma of the vagina Disease
Mucinous carcinoma, gastric type, of the vagina Disease
Mucinous carcinoma, intestinal type, of the vagina Disease
Mesonephric adenocarcinoma of the vagina Disease
Carcinosarcoma of the vagina Disease
Mixed tumour of the vagina Disease
Adenocarcinoma of Skene gland origin Disease
Adenosquamous carcinoma of the vagina Disease
Adenosarcoma of the vagina Disease
Germ cell tumours of the vagina Disease

CHAPTER 11 (TUMOURS OF THE VULVA)
Seborrhoeic keratosis Disease
Condyloma acuminatum Disease
Squamous intraepithelial lesions, HPV-associated, of the vulva Disease
Vulvar intraepithelial neoplasia, HPV-independent Disease
Squamous cell carcinoma, HPV-associated, of the vulva Disease
Squamous cell carcinoma, HPV-independent, of the vulva Disease
Papillary hidradenoma Disease
Chondroid syringoma Disease
Fibroadenoma Disease
Phyllodes tumour Disease
Adenocarcinoma of mammary gland type Disease
Bartholin gland cyst Disease
Bartholin gland hyperplasia, adenoma, and adenomyoma Disease
Bartholin gland carcinomas Disease
Other cysts of the vulva Disease
Paget disease Disease
Carcinomas of sweat gland origin Disease
Adenocarcinoma of intestinal type Disease
Germ cell tumours of the vulva Disease

CHAPTER 12 (NEUROENDOCRINE NEOPLASIA)
Neuroendocrine tumour Disease
Small cell neuroendocrine carcinoma Disease
Large cell neuroendocrine carcinoma Disease
Carcinoma admixed with neuroendocrine carcinoma Disease

CHAPTER 13 (HAEMATOLYMPHOID PROLIFERATIONS AND NEOPLASIA)
Florid reactive lymphoid hyperplasia Disease
Diffuse large B-cell lymphoma Disease
Extranodal marginal zone lymphoma Disease
Follicular lymphoma Disease
Burkitt lymphoma Disease
Myeloid sarcoma Disease

CHAPTER 14 (MESENCHYMAL TUMOURS OF THE LOWER GENITAL TRACT)
Lipoma Disease
Lipoblastoma-like tumour of the vulva Disease
Liposarcoma Disease
Postoperative spindle cell nodule Disease
Fibroepithelial stromal polyp Disease
Prepubertal fibroma Disease
Superficial myofibroblastoma Disease
Myofibroblastoma Disease
Cellular angiofibroma Disease
Angiomyofibroblastoma Disease
Solitary fibrous tumour of the lower genital tract Disease
Dermatofibrosarcoma protuberans Disease
NTRK-rearranged spindle cell neoplasm (emerging) Disease
Kaposi sarcoma Disease
Angiosarcoma Disease
Leiomyoma of the lower genital tract Disease
Smooth muscle tumour of uncertain malignant potential of the lower genital tract Disease
Leiomyosarcoma of the lower genital tract Disease
Rhabdomyoma Disease
Rhabdomyosarcoma Disease
Benign peripheral nerve sheath tumours Disease
Granular cell tumour Disease
Superficial angiomyxoma Disease
Deep (aggressive) angiomyxoma Disease
Epithelioid sarcoma Disease
Alveolar soft part sarcoma Disease
Ewing sarcoma Disease

CHAPTER 15 (MELANOCYTIC LESIONS)
Acquired melanocytic naevus Disease
Congenital melanocytic naevus Disease
Blue naevus Disease
Atypical melanocytic naevus of genital type Disease
Dysplastic melanocytic naevus Disease
Mucosal melanoma Disease

CHAPTER 16 (METASTASIS)
Metastasis to the lower female genital tract Disease

CHAPTER 17 (GENETIC TUMOUR SYNDROMES OF THE FEMALE GENITAL TRACT)
BRCA1/2-associated hereditary breast and ovarian cancer syndrome Disease See GTS5 volunteer sheet for authorship status N/A N/A N/A N/A N/A N/A N/A
Lynch syndrome Disease See GTS5 volunteer sheet for authorship status N/A N/A N/A N/A N/A N/A N/A
Cowden syndrome Disease See DIG5 volunteer sheet for authorship status N/A N/A N/A N/A N/A N/A N/A
Li-Fraumeni syndrome Disease See GTS5 volunteer sheet for authorship status N/A N/A N/A N/A N/A N/A N/A
Peutz-Jeghers syndrome Disease See GTS5 volunteer sheet for authorship status N/A N/A N/A N/A N/A N/A N/A
Ataxia-telangiectasia Disease See GTS5 volunteer sheet for authorship status N/A N/A N/A N/A N/A N/A N/A
Carney complex Disease
DICER1 syndrome Disease See GTS5 volunteer sheet for authorship status N/A N/A N/A N/A N/A N/A N/A
Ovarian dysgenesis Disease
Von Hippel-Lindau syndrome Disease See GTS5 volunteer sheet for authorship status N/A N/A N/A N/A N/A N/A N/A
Hereditary leiomyomatosis and renal cell carcinoma Disease
Other genetic tumour syndromes of the female genital tract Disease
Retrieved from "https://ccga.io/index.php?title=FEMA5:Volunteer_Assignments_and_Opportunities&oldid=15427"